Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$798M |
| 2 |
Netflix
NFLX
|
+$608M |
| 3 |
UnitedHealth
UNH
|
+$517M |
| 4 |
Apple
AAPL
|
+$461M |
| 5 |
GE Vernova
GEV
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$527M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$372M |
| 3 |
Meta Platforms (Facebook)
META
|
+$362M |
| 4 |
Advanced Micro Devices
AMD
|
+$328M |
| 5 |
Palantir
PLTR
|
+$327M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Healthcare | 15.79% |
| 3 | Consumer Discretionary | 12.36% |
| 4 | Financials | 11.53% |
| 5 | Industrials | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2251
Apple Hospitality REIT
APLE
$3.91B
| $1.6M | ﹤0.01% |
137,500
-16,100
| -10% | -$189K |
2025 Q1
1 quarter
|
|
2252
Old Republic International
ORI
$9.21B
| $1.6M | ﹤0.01% |
41,685
-20,400
| -33% | -$768K |
2015 Q3
39 quarters
|
|
2253
State Street SPDR S&P Dividend ETF
SDY
$21B
| $1.6M | ﹤0.01% |
11,800
-17,600
| -60% | -$2.33M |
2024 Q1
5 quarters
|
|
2254
Capital Bancorp
CBNK
$631M
| $1.6M | ﹤0.01% |
47,500
+800
| +2% | +$24.5K |
2024 Q2
4 quarters
|
|
2255
Crexendo
CXDO
$193M
| $1.59M | ﹤0.01% |
262,400
+82,000
| +45% | +$428K |
2022 Q4
10 quarters
|
|
2256
Berkshire Hathaway Class B
BRK.B
$1.11T
| $1.59M | ﹤0.01% |
3,268
+1,232
| +61% | +$626K |
2024 Q1
5 quarters
|
|
2257
Peoples Financial Services
PFIS
$681M
| $1.59M | ﹤0.01% |
32,112
-1,800
| -5% | -$83.4K |
2015 Q3
39 quarters
|
|
2258
iShares MSCI USA Value Factor ETF
VLUE
$9.26B
| $1.58M | ﹤0.01% |
14,000
+6,000
| +75% | +$633K |
2025 Q1
1 quarter
|
|
2259
Comstock Holding Companies
CHCI
$186M
| $1.58M | ﹤0.01% |
156,979
+800
| +0.5% | +$7.95K |
2018 Q2
28 quarters
|
|
2260
Gold Royalty Corp
GROY
$672M
| $1.58M | ﹤0.01% |
715,700
-102,500
| -13% | -$180K |
2024 Q2
4 quarters
|
|
2261
People Inc
PPLI
$3.04B
| $1.57M | ﹤0.01% |
+42,127
| New | +$1.52M |
2025 Q2
0 quarters
|
|
2262
CB Financial Services
CBFV
$191M
| $1.57M | ﹤0.01% |
55,116
+6,217
| +13% | +$177K |
2018 Q2
28 quarters
|
|
2263
Lionsgate Studios
LION
$3.31B
| $1.57M | ﹤0.01% |
+270,272
| New | +$1.81M |
2025 Q2
0 quarters
|
|
2264
MaxCyte
MXCT
$99.5M
| $1.56M | ﹤0.01% |
717,800
+349,900
| +95% | +$847K |
2023 Q1
9 quarters
|
|
2265
C4 Therapeutics
CCCC
$342M
| $1.56M | ﹤0.01% |
1,093,188
+878,688
| +410% | +$1.28M |
2025 Q1
1 quarter
|
|
2266
American Well
AMWL
$207M
| $1.56M | ﹤0.01% |
175,423
+500
| +0.3% | +$3.57K |
2021 Q4
14 quarters
|
|
2267
DELISTED
Astria Therapeutics
ATXS
| $1.55M | ﹤0.01% |
289,778
+110,617
| +62% | +$536K |
2025 Q1
1 quarter
|
|
2268
Cato Corp
CATO
$46.6M
| $1.55M | ﹤0.01% |
551,302
-9,200
| -2% | -$24.5K |
2018 Q3
27 quarters
|
|
|
PLYM
2269
DELISTED
Plymouth Industrial REIT
PLYM
| $1.55M | ﹤0.01% |
96,392
-40,820
| -30% | -$638K |
2018 Q3
27 quarters
|
|
2270
Sypris Solutions
SYPR
$43.8M
| $1.54M | ﹤0.01% |
698,821
-12,900
| -2% | -$23.2K |
2013 Q2
48 quarters
|
|
2271
Axogen
AXGN
$2.12B
| $1.54M | ﹤0.01% |
142,000
+80,000
| +129% | +$1.05M |
2024 Q4
2 quarters
|
|
2272
Vanguard Morningstar Large-Cap ETF
VV
$55.2B
| $1.54M | ﹤0.01% |
+5,400
| New | +$1.42M |
2025 Q2
0 quarters
|
|
2273
U.S. Small Cap Value Portfolio ETF Class Shares
DFSV
$8.1B
| $1.54M | ﹤0.01% |
52,300
-10,400
| -17% | -$288K |
2024 Q4
2 quarters
|
|
2274
State Street SPDR S&P Bank ETF
KBE
$1.46B
| $1.54M | ﹤0.01% |
+27,600
| New | +$1.44M |
2025 Q2
0 quarters
|
|
2275
Dimensional US Large Cap Value ETF
DFLV
$7.14B
| $1.54M | ﹤0.01% |
+49,500
| New | +$1.47M |
2025 Q2
0 quarters
|
|
Similar funds
Renaissance Technologies's Q2 2025 Portfolio in Review
As of Q2 2025, Renaissance Technologies held 4,018 positions worth $75.2B, up 14% from $66.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies's Q2 2025 filing shows 612 new, 1,577 increased, 1,314 reduced and 496 closed positions. Its largest new stake was UnitedHealth: 1,352,129 shares worth $422M. The largest sale was Broadcom, an estimated $527M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q2 2025 buy was UnitedHealth: 1,352,129 shares worth $422M.
- Renaissance Technologies added most to NVIDIA in Q2 2025, an estimated $798M increase.
- Renaissance Technologies's biggest Q2 2025 reduction was Broadcom, cutting an estimated $527M.
- Renaissance Technologies fully exited Advanced Micro Devices in Q2 2025, selling an estimated $328M.
- Renaissance Technologies's ten largest holdings make up 12% of its $75.2B portfolio in Q2 2025.
- Renaissance Technologies opened 612 new positions and closed 496 in Q2 2025.
- Renaissance Technologies's portfolio value rose 14% quarter-over-quarter to $75.2B.
Based on Renaissance Technologies's 13F filing for Q2 2025, filed 13 Aug 2025.